AβCC patent validated in 24 European countries
Alzinova’s AβCC patent has now been validated in 24 European countries comprising a very large potential market with around 540 million people. It follows issuances in Australia, China, and Japan. It is still pending in other major markets.
The european countries that have validated the patent are: Austria, Belgium, Croatia, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Lichtenstein, Luxemburg, Malta, Monaco, the Netherlands, Norway, Poland, Spain, Sweden, Switzerland, Turkey, and the United Kingdom.